| Treatment of adenoviral acute respiratory distress syndrome using cidofovir with extracorporeal membrane oxygenation: case series and literature review M Lee, S Kim, OJ Kwon, JH Kim, I Jeong, JW Son, MJ Na, YS Yoon, ... Journal of Intensive Care Medicine 32 (3), 231-238, 2017 | 29 | 2017 |
| Comparative efficacy and tolerability of third-line treatments for advanced gastric cancer: A systematic review with Bayesian network meta-analysis S Park, CM Nam, SG Kim, JE Mun, SY Rha, HC Chung European Journal of Cancer 144, 49-60, 2021 | 27 | 2021 |
| High serum levels of IL-6 predict poor responses in patients treated with pembrolizumab plus axitinib for advanced renal cell carcinoma YB Sang, H Yang, WS Lee, SJ Lee, SG Kim, J Cheon, B Kang, CW Kim, ... Cancers 14 (23), 5985, 2022 | 19 | 2022 |
| On-treatment derived neutrophil-to-lymphocyte ratio and survival with palbociclib and endocrine treatment: analysis of a multicenter retrospective cohort and the PALOMA-2/3 … CG Kim, MH Kim, JH Kim, SG Kim, GM Kim, TY Kim, WJ Ryu, JY Kim, ... Breast Cancer Research 25 (1), 4, 2023 | 13 | 2023 |
| A case report of re-challenge of immune checkpoint inhibitors after immune-related neurological adverse events: Review of literature H Moon, SG Kim, SK Kim, J Kim, SR Lee, YW Moon Medicine 101 (36), e30236, 2022 | 8 | 2022 |
| Combined PI3K inhibitor and eribulin enhances anti-tumor activity in preclinical models of paclitaxel-resistant, PIK3CA-mutated endometrial cancer YG Jeong, NB Katuwal, MS Kang, M Ghosh, SD Hong, SM Park, SG Kim, ... Cancers 15 (19), 4887, 2023 | 7 | 2023 |
| Copy number aberrations in circulating tumor DNA enables prognosis prediction and molecular characterization of breast cancer MH Kim, GM Kim, JM Ahn, WJ Ryu, SG Kim, JH Kim, TY Kim, HJ Han, ... JNCI: Journal of the National Cancer Institute 115 (9), 1036-1049, 2023 | 7 | 2023 |
| Targeting PEG10 as a novel therapeutic approach to overcome CDK4/6 inhibitor resistance in breast cancer NB Katuwal, MS Kang, M Ghosh, SD Hong, YG Jeong, SM Park, SG Kim, ... Journal of Experimental & Clinical Cancer Research 42 (1), 325, 2023 | 6 | 2023 |
| Efficacy of limited dose modifications for palbociclib-related grade 3 neutropenia in hormone receptor–positive metastatic breast cancer SG Kim, MH Kim, S Park, GM Kim, JH Kim, JY Kim, HS Park, S Park, ... Cancer Research and Treatment 55 (4), 1198-1209, 2023 | 5 | 2023 |
| Copy number aberration burden on circulating tumor DNA predicts recurrence risk after neoadjuvant chemotherapy in patients with triple-negative breast cancer: Post-hoc analysis … MH Kim, GM Kim, SG Kim, JM Ahn, JH Kim, J Kim, HS Park, S Park, ... Journal of Clinical Oncology 40 (16_suppl), 603-603, 2022 | 4 | 2022 |
| PSPC1 inhibition synergizes with Poly (ADP-ribose) polymerase inhibitors in a preclinical Model of BRCA-Mutated Breast/Ovarian cancer M Ghosh, MS Kang, NB Katuwal, SD Hong, YG Jeong, SM Park, SG Kim, ... International Journal of Molecular Sciences 24 (23), 17086, 2023 | 3 | 2023 |
| Preclinical platform using a triple-negative breast cancer syngeneic murine model to evaluate immune checkpoint inhibitors NB Katuwal, N Park, K Pandey, MS Kang, SD Hong, M Ghosh, SG Kim, ... Anticancer Research 43 (1), 85-95, 2023 | 3 | 2023 |
| Anaemia and pathologic complete response rate according to carboplatin dose in HER2+ breast cancer treated with neoadjuvant TCHP JH Ji, SJ Bae, SG Kim, MH Kim, GM Kim, J Sohn, J Jeong, JH Kim, ... Cancer medicine 12 (2), 1409-1417, 2023 | 3 | 2023 |
| Bioelectrical impedance analysis is not sufficient for determining water deficit in hypernatremic patients SH Yoon, S Kim, IB Jeong, WM Hwang, SR Yun Medical science monitor: international medical journal of experimental and …, 2019 | 3 | 2019 |
| MicroRNA 181a-5p reprogrammed glucose and lipid metabolism in lung cancer though regulating SIRT1 and ACSL4 JW Son, SG Kim, IB Jeong, SJ Kwon Cancer Research 78 (13_Supplement), 4417-4417, 2018 | 3 | 2018 |
| Abstract PO2-27-09: Clinical impact of routine MRI screening for brain metastases in patients with HER2 positive or triple negative metastatic breast cancer GM Kim, JH Sohn, MH Kim, SG Kim, HS Park, JH Jang, YB Kim, S Lee Cancer Research 84 (9_Supplement), PO2-27-09-PO2-27-09, 2024 | 2 | 2024 |
| Impact of Coronavirus Disease 2019 on Unresectable Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab YB Sang, C Lee, SG Kim, B Lee, B Kang, C Kim, HJ Chon Journal of Clinical Medicine 13 (5), 1335, 2024 | 1 | 2024 |
| JPI-547, a novel dual inhibitor of PARP 1/2 and tankyrase 1/2 overcomes olaparib resistance in BRCA 1/2 mutant ovary and breast cancer preclinical model MS Kang, N Katuwal, M Ghosh, Y Jeong, S deok Hong, SM Park, J Kim, ... Cancer Research 83 (7_Supplement), 4485-4485, 2023 | 1 | 2023 |
| Abstract P1-17-09: Efficacy of limited dose modifications for palbociclib-related grade 3 neutropenia in hormone receptor positive metastatic breast cancer SG Kim, MH Kim, S Park, GM Kim, JH Kim, JY Kim, HS Park, S Park, ... Cancer Research 82 (4_Supplement), P1-17-09-P1-17-09, 2022 | 1 | 2022 |
| Abstract P1-19-03: Phase II trial of durvalumab and tremelimumab in the hormone receptor-positive metastatic breast cancer with high tumor mutational burden selected by whole … YW Moon, E Kim, MH Kim, GM Kim, SG Kim, YS Chae, J Lee, JH Jeong, ... Cancer Research 82 (4_Supplement), P1-19-03-P1-19-03, 2022 | 1 | 2022 |
